In addition, a nonclinical study has indicated that the presence of extracellular proteases, such as cathepsin L, within the tumor microenvironment may contribute to the activity of T-DXd in HER2-low and HER2-ultralow tumors [55]. The gene discussed is ERBB2; the disease is neoplasm.